HCAR2 and atherosclerosis: Gpr109a is a G‐protein coupled receptor (GPCRs) expressed on adipocytes, macrophages, and neutrophils.[15] Activation of Gpr109a by niacin (NA) reduces progression of atherosclerosis via exerting a lipid lowering effect as well as a direct anti‐inflammatory property.[16, 17]